Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05265312 · ClinicalTrials.gov registry record · NA
Implementation and Evaluation of a Diabetes Prevention Clinical Pathway in Primary Care
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 1,910
- Enrollment target
NCT05265312: Completed NA study, sponsored by Johns Hopkins University.
NCT05265312 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 1,910 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05265312, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,910 participants
- Enrollment target
Study Summary
Prediabetes is a significant public health problem affecting 88 million U.S. adults. Evidence suggest that the vast majority of people with prediabetes are unaware of having this condition and many are not receiving appropriate care for prediabetes, including referral to evidence-based programs like the Diabetes Prevention Programs (DPP). In the investigator's retrospective cohort study of patients with prediabetes from Johns Hopkins Health Systems, the investigators found that the rates of prediabetes clinical care activities are low. In the investigators' qualitative studies, the investigators found that primary care physician (PCP) barriers include low knowledge about Diabetes Prevention Programs and misperceptions of insurance coverage of these programs and inadequate clinical staff to address prediabetes. Common patient barriers to taking action to prevent diabetes include lack of motivation, time and resources. Based on prior research, comprehensive strategies are urgently needed to improve prediabetes care. Using these findings, the investigators have designed and plan to implement a diabetes prevention clinical pathway which seeks to address some of these common clinician and patient barriers. The investigators hypothesize that the clinical pathway will result in increased clinician screening and intervention and improve patient engagement in diabetes prevention. The investigators will compare results from the intervention clinic compared to a control clinic. If successful, the investigators plan to implement and test the effectiveness of this clinical pathway across the entire health system.
Interventions
- OTHER START diabetes prevention clinical pathway
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,910 participants |
| Start Date | 2022-05-31 |
| Est. Completion | 2023-07-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05265312
The ClinicalTrials.gov registry entry for NCT05265312 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,910 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which START diabetes prevention clinical pathway is the first listed.
NCT05265312 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05265312 about?
NCT05265312 is a clinical study titled "Implementation and Evaluation of a Diabetes Prevention Clinical Pathway in Primary Care". Prediabetes is a significant public health problem affecting 88 million U.S. adults. Evidence suggest that the vast majority of people with prediabetes are unaware of having this condition and many are not receiving appropriate care for prediabetes, including referral to evidence-based programs like...
What is the current status of trial NCT05265312?
This trial is currently completed. It is a NA study. The enrollment target is 1,910 participants. The study started on 2022-05-31. Estimated completion is 2023-07-02.
What interventions are being tested in trial NCT05265312?
The interventions under investigation include: START diabetes prevention clinical pathway (OTHER).
Who is sponsoring clinical trial NCT05265312?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.